Finance

Lists
214390:KRX
Kyongbo Pharmaceutical Co Ltd
5 350,00 ₩
+1,90%
(+100,00) 1D
19 հոկ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214390...
Open
5 250 ₩
High
5 420 ₩
Low
5 250 ₩
Mkt. cap
127,90 մլրդ
Avg. vol.
24,96 հզր
Volume
15,49 հզր
Dividend
0,93%
Quarterly dividend
12 ₩
Ex-dividend date
29 դեկ, 2025 թ.
P/E ratio
25,41
52-wk high
9 300 ₩
52-wk low
4 700 ₩
EPS
211 ₩
Shares outstanding
23,91 մլն
No. of employees
588
Open
5 250 ₩
High
5 420 ₩
Low
5 250 ₩
Mkt. cap
127,90 մլրդ
Avg. vol.
24,96 հզր
Volume
15,49 հզր
Dividend
0,93%
Quarterly dividend
12 ₩
Ex-dividend date
29 դեկ, 2025 թ.
P/E ratio
25,41
52-wk high
9 300 ₩
52-wk low
4 700 ₩
EPS
211 ₩
Shares outstanding
23,91 մլն
No. of employees
588
News stories
From web sources and news partners
About Kyongbo Pharmaceutical Co Ltd
CEOKim Tae-young
Employees588
Founded31 մրտ, 1987 թ.
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
66,99 մլրդ
71,22 մլրդ
66,13 մլրդ
75,22 մլրդ
Cost of goods sold
42,39 մլրդ
44,46 մլրդ
38,69 մլրդ
46,54 մլրդ
Cost of revenue
42,39 մլրդ
44,46 մլրդ
38,69 մլրդ
46,54 մլրդ
Research and development expenses
4,46 մլրդ
4,50 մլրդ
4,92 մլրդ
4,99 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,88 մլրդ
20,67 մլրդ
20,97 մլրդ
21,99 մլրդ
Operating expense
24,12 մլրդ
26,24 մլրդ
26,73 մլրդ
27,75 մլրդ
Total operating expenses
66,51 մլրդ
70,70 մլրդ
65,41 մլրդ
74,29 մլրդ
Operating income
474,48 մլն
515,50 մլն
712,77 մլն
930,33 մլն
Other non operating income
-1,10 մլրդ
2,51 մլրդ
-1,44 մլրդ
3,36 մլրդ
EBT including unusual items
3,44 մլրդ
-995,05 մլն
-741,91 մլն
4,27 մլրդ
EBT excluding unusual items
3,44 մլրդ
-857,95 մլն
-741,91 մլն
4,27 մլրդ
Income tax expense
412,26 մլն
-562,40 մլն
-212,24 մլն
1,29 մլրդ
Effective tax rate
11,97%
56,52%
28,61%
30,33%
Other operating expenses
194,62 մլն
276,72 մլն
190,08 մլն
187,64 մլն
Net income
3,03 մլրդ
-432,65 մլն
-529,67 մլն
2,97 մլրդ
Net profit margin
4,53%
-0,61%
-0,80%
3,95%
Earnings per share
-
-
-
-
Interest and investment income
-
41,30 մլն
-
-
Interest expense
-
-4,29 մլրդ
-
-
Net interest expenses
-
-4,25 մլրդ
-
-
Depreciation and amortization charges
377,69 մլն
385,22 մլն
323,46 մլն
327,67 մլն
EBITDA
3,86 մլրդ
3,95 մլրդ
4,29 մլրդ
4,64 մլրդ
Gain or loss from assets sale
-6,40 մլն
10,00 հզր
-5,48 մլն
13,90 մլն
AI content may include mistakes. Learn more
Google Apps